Changes in the Cerebrospinal Fluid Ceramide Profile After Subarachnoid Hemorrhage

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Stroke

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.112.650390PMID 22713492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2012cited by this paper
• FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice.

  2011cited by this paper
• Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries.

  2011cited by this paper
• Fingolimod provides long‐term protection in rodent models of cerebral ischemia

  2011cited by this paper
• Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

  2011cited by this paper
• Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry.

  2011cited by this paper
• Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

  2011cited by this paper
• Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation.

  2011cited by this paper
• Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats

  2010cited by this paper
• Blood sphingolipidomics in healthy humans: impact of sample collection methodology

  2010cited by this paper
• Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus

  2010cited by this paper
• Lipidomics reveals a remarkable diversity of lipids in human plasma1[S]

  2010cited by this paper
• Oxidized phosphatidylcholine formation and action in oligodendrocytes

  2009cited by this paper
• Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.

  2009cited by this paper
• Ceramide and Mitochondria in Ischemia/Reperfusion

  2009cited by this paper
• Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia

  2009cited by this paper
• Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.

  2008cited by this paper
• Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia.

  2008cited by this paper
• Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide

  2007cited by this paper
• Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

  2007cited by this paper
• JNK3 Signaling Pathway Activates Ceramide Synthase Leading to Mitochondrial Dysfunction*

  2007cited by this paper
• De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.

  2006cited by this paper
• Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study

  2005cited by this paper
• Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress.

  2004cited by this paper
• Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia

  2004cited by this paper
• Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

  2004cited by this paper
• Regulation of sphingomyelinases in cells of the oligodendrocyte lineage

  2004cited by this paper
• Glucosylceramide Synthase Activity and Ceramide Levels are Modulated during Cerebral Ischemia after Ischemic Preconditioning

  2004cited by this paper
• Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia.

  2004cited by this paper
• Ceramide in rafts (detergent‐insoluble fraction) mediates cell death in neurotumor cell lines

  2003cited by this paper
• Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke.

  2002cited by this paper
• Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis

  2000cited by this paper
• Sphingomyelinase and ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle.

  2000cited by this paper
• Effect of ceramide on KCa channel activity and vascular tone in coronary arteries.

  1999cited by this paper
• Sphingomyelinase and Ceramide Stimulate the Expression of Inducible Nitric-oxide Synthase in Rat Primary Astrocytes*

  1998cited by this paper
• Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

  1994cited by this paper
• Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association

  1994cited by this paper

• Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery

  2025cites this paper
• Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage

  2024cites this paper
• Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases

  2024cites this paper
• Ceramide in cerebrovascular diseases

  2023cites this paper
• Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates

  2023cites this paper
• Early metabolic disruption and predictive biomarkers of delayed-cerebral ischemia in aneurysmal subarachnoid haemorrhage

  2023cites this paper
• Early Metabolic Disruption and Predictive Biomarkers of Delayed-Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.

  2023cites this paper
• Distinct Cerebrospinal Fluid Lipid Signature in Patients with Subarachnoid Hemorrhage-Induced Hydrocephalus

  2023cites this paper
• Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease

  2022cites this paper
• Sphingolipids in ischemic stroke

  2022cites this paper
• Plasma ceramides are associated with outcomes in acute ischemic stroke patients.

  2021cites this paper
• Differential Expression of Sphingolipid Metabolizing Enzymes in Spontaneously Hypertensive Rats: A Possible Substrate for Susceptibility to Brain and Kidney Damage

  2021cites this paper
• Neonatal stroke enhances interaction of microglia-derived extracellular vesicles with microglial cells.

  2021cites this paper
• Changes in the cerebrospinal fluid lipid profile following subarachnoid hemorrhage in a closed cranium model: Correlations to cerebral vasospasm, neuronal cell death and Interleukin-6 synthesis. A pilot study.

  2020cites this paper
• Ceramide Dynamics and Prognostic Value in Acute and Subacute Ischemic Stroke: Preliminary Findings in a Clinical Cohort

  2020cites this paper
• Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment

  2020cites this paper
• Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis.

  2020cites this paper
• Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment

  2020cites this paper
• Sphingolipidomics investigation of the temporal dynamics after ischemic brain injury.

  2019cites this paper
• Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.

  2019cites this paper
• Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications.

  2018cites this paper
• C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease

  2017cites this paper
• Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets

  2016cites this paper
• Changes in the metabolism of sphingolipids after subarachnoid hemorrhage

  2015cites this paper
• Controversies and evolving new mechanisms in subarachnoid hemorrhage.

  2014cites this paper
• Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia

  2014cites this paper
• Application of proteomics to cerebrovascular disease

  2012cites this paper